(NASDAQ: AIRS) Airsculpt Technologies's forecast annual revenue growth rate of 12.97% is forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 6.18%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.3%.
Airsculpt Technologies's revenue in 2024 is $195,917,000.On average, 3 Wall Street analysts forecast AIRS's revenue for 2024 to be $12,579,835,965, with the lowest AIRS revenue forecast at $12,541,592,749, and the highest AIRS revenue forecast at $12,634,042,565. On average, 3 Wall Street analysts forecast AIRS's revenue for 2025 to be $14,467,707,146, with the lowest AIRS revenue forecast at $14,243,013,898, and the highest AIRS revenue forecast at $14,609,367,827.
In 2026, AIRS is forecast to generate $15,995,827,957 in revenue, with the lowest revenue forecast at $15,821,551,440 and the highest revenue forecast at $16,170,104,474.